8-22995709-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001160036.2(RHOBTB2):c.56+1070C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00577 in 747,402 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 91 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 45 hom. )
Consequence
RHOBTB2
NM_001160036.2 intron
NM_001160036.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00200
Genes affected
RHOBTB2 (HGNC:18756): (Rho related BTB domain containing 2) The protein encoded by this gene is a small Rho GTPase and a candidate tumor suppressor. The encoded protein interacts with the cullin-3 protein, a ubiquitin E3 ligase necessary for mitotic cell division. This protein inhibits the growth and spread of some types of breast cancer. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
PEBP4 (HGNC:28319): (phosphatidylethanolamine binding protein 4) The phosphatidylethanolamine (PE)-binding proteins, including PEBP4, are an evolutionarily conserved family of proteins with pivotal biologic functions, such as lipid binding and inhibition of serine proteases (Wang et al., 2004 [PubMed 15302887]).[supplied by OMIM, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 8-22995709-C-G is Benign according to our data. Variant chr8-22995709-C-G is described in ClinVar as [Benign]. Clinvar id is 1243399.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOBTB2 | NM_001160036.2 | c.56+1070C>G | intron_variant | Intron 3 of 11 | NP_001153508.1 | |||
RHOBTB2 | XM_047421607.1 | c.56+1070C>G | intron_variant | Intron 3 of 11 | XP_047277563.1 | |||
RHOBTB2 | XM_047421608.1 | c.56+1070C>G | intron_variant | Intron 3 of 11 | XP_047277564.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOBTB2 | ENST00000519685.5 | c.56+1070C>G | intron_variant | Intron 3 of 11 | 1 | ENSP00000427926.1 | ||||
RHOBTB2 | ENST00000524077.5 | c.56+1070C>G | intron_variant | Intron 3 of 5 | 3 | ENSP00000430785.1 | ||||
PEBP4 | ENST00000522278.1 | c.144+3970G>C | intron_variant | Intron 1 of 1 | 5 | ENSP00000429414.1 |
Frequencies
GnomAD3 genomes AF: 0.0191 AC: 2899AN: 152174Hom.: 91 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2899
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00237 AC: 1411AN: 595110Hom.: 45 AF XY: 0.00196 AC XY: 615AN XY: 313456 show subpopulations
GnomAD4 exome
AF:
AC:
1411
AN:
595110
Hom.:
AF XY:
AC XY:
615
AN XY:
313456
Gnomad4 AFR exome
AF:
AC:
1063
AN:
15806
Gnomad4 AMR exome
AF:
AC:
132
AN:
28354
Gnomad4 ASJ exome
AF:
AC:
0
AN:
16716
Gnomad4 EAS exome
AF:
AC:
0
AN:
31842
Gnomad4 SAS exome
AF:
AC:
6
AN:
55276
Gnomad4 FIN exome
AF:
AC:
0
AN:
44770
Gnomad4 NFE exome
AF:
AC:
54
AN:
368538
Gnomad4 Remaining exome
AF:
AC:
153
AN:
30790
Heterozygous variant carriers
0
64
128
191
255
319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0190 AC: 2899AN: 152292Hom.: 91 Cov.: 32 AF XY: 0.0179 AC XY: 1333AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
2899
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
1333
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.0651054
AN:
0.0651054
Gnomad4 AMR
AF:
AC:
0.00856209
AN:
0.00856209
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207125
AN:
0.000207125
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000294023
AN:
0.000294023
Gnomad4 OTH
AF:
AC:
0.0198488
AN:
0.0198488
Heterozygous variant carriers
0
139
279
418
558
697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at